What's hidden in plain sight? Impact of clonal hematopoiesis on the risk and progression of nonhematologic cancers.

Haematologica · 2026 · PMC13136831 · PMID 40905095

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendP =0.079so close (0.05 < p ≤ 0.1)

In the PA.7 trial involving patients with metastatic pancreatic adenocarcinoma, individuals with CH treated with immune checkpoint inhibitors showed a trend toward improved progression-free survival (PFS) (HR=0.55; 95% CI: 0.28–1.07; P =0.079).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.